Cancer Letters
Volume 241, Issue 1 , Pages 135-141 , 8 September 2006

Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma

  • Danai Tiwawech

      Affiliations

    • Research Division, National Cancer Institute, Bangkok 10400, Thailand
    • Unit of Human Biology and Genetics, Department of Biological Sciences, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
    • ,
  • Petcharin Srivatanakul

      Affiliations

    • Research Division, National Cancer Institute, Bangkok 10400, Thailand
    • ,
  • Anant Karalak

      Affiliations

    • Pathology Division, National Cancer Institute, Bangkok 10400, Thailand
    • ,
  • Takafumi Ishida

      Affiliations

    • Unit of Human Biology and Genetics, Department of Biological Sciences, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 5841 4633; fax: +81 3 3818 7547.

Received 11 July 2005 ,Revised 10 October 2005 ,Accepted 12 October 2005.

References 

  1. McDermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin. Otolaryngol. Allied Sci. 2001;26:82–90
  2. In:  Parkin DM,  Whelan SL,  Raymond JF,  Young J editor. Cancer Incidence in Five Continents. IARC Scientific Publications No. 143, Lyon. vol. VI:1997;p. 814–815
  3. S. Deerasamee, N. Martin, S. Sontipong, S. Sriamporn, H. Sriplung, P. Srivatanakul, V. Vatanasapt, D.M. Parkin, J. Ferlay (Eds.), Cancer in Thailand, vol. 2 1992–1994, IARC Technical Report No. 34, Lyon, 1999, pp. 30–32.
  4. Shanmugaratnam K, Sobin LH. The World Health Organization histological classification of tumours upper respiratory tract and ear. A commentary on the second edition. Cancer. 1993;71:2689–2697
  5.  Fleming ID,  Cooper JS,  Henson DE,  Hutter RVP,  Kennedy BJ,  Murphy GP, et al.AJCC Cancer Staging Manual, fifth ed., Lippincott–Raven, Philadelphia, PA,. 1997;
  6. Wolf H, zur Hausen H, Becker V. EB virus genomes in epithelial nasopharyngeal carcinoma cells. Nature. 1973;244:245–247
  7. Zheng YM, Tuppin P, Hubert A, Jeannel D, Pan YJ, Zeng Y, et al. Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China. Br. J. Cancer. 1994;69:508–514
  8. Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature. 1990;346:470–471
  9. Kongruttanachok N, Sukdikul S, Setavarin S, Kerekhjanarong V, Supiyaphun P, Voravud N, et al. Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer. 2001;1:4–8
  10. Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 1999;8:547–551
  11. Aoyama T, Yamano S, Guzelian PS, Gelboin HV, Gonzalez FJ. Five of 12 forms of vaccinia virus-expressed human cytochrome P450 metabolically activate aflatoxin B1. Proc. Natl Acad. Sci. USA. 1990;87:4790–4793
  12. Crespi CL, Penman BW, Leakey JA, Arlotto MP, Stark A, Parkinson A, et al. Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis. 1990;11:1293–1300
  13. Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic cytochrome P4502D6. Carcinogenesis. 1991;12:1197–1201
  14. Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkyl-amines and tobacco-related nitrosoamines in human liver microsomes. Carcinogenesis. 1992;13:1789–1794
  15. Ariyoshi N, Miyamoto M, Umetsu Y, Kunitoh H, Dosaka-Akita H, Sawamura Y, et al. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol. Biomarkers Prev. 2002;11:890–894
  16. Tsukino H, Kuroda Y, Qiu D, Nakao H, Imai H, Katoh T. Effects of cytochrome P-450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma. Int. J. Cancer. 2002;100:425–428
  17. Tan W, Chen GF, Xing DY, Song CY, Kadlubar FF, Lin DX. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int. J. Cancer. 2001;95:96–101
  18. Miyamoto M, Umetsu Y, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, et al. CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem. Biophys. Res. Commun. 1999;261:658–660
  19. Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, et al. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis. 2004;25:2451–2458
  20. Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics. 1992;2:227–233
  21. Yun CH, Shimada T, Guengerich FP. Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol. Pharmacol. 1991;40:679–685
  22. Su T, Sheng JJ, Lipinskas TW, Ding X. Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab. Dispos. 1996;24:884–890
  23. Hellmold H, Rylander T, Magnusson M, Reihner E, Warner M, Gustafsson JA. Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties. J. Clin. Endocrinol. Metab. 1998;83:886–895
  24. Crawford EL, Weaver DA, DeMuth JP, Jackson CM, Khuder SA, Frampton MW, et al. Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis. 1998;19:1867–1871
  25. Mace K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AM. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer. 1998;34:914–920
  26. Furukawa M, Nishimura M, Ogino D, Chiba R, Ikai I, Ueda N, et al. Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci. 2004;95:520–529
  27. Fernandez-Salguero P, Hoffman SM, Cholerton S, Mohrenweiser H, Raunio H, Rautio A, et al. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet. 1995;57:651–660
  28. London SJ, Idle JR, Daly AK, Coetzee GA. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet. 1999;353:898–899
  29. Ariyoshi N, Takahashi Y, Miyamoto M, Umetsu Y, Daigo S, Tateishi T, et al. Structure characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogenetics. 2000;10:687–693
  30. Kamataki T, Nunoya K, Sakai Y, Kushida H, Fujita K. Genetic polymorphism of CYP2A6 in relation to cancer. Mutat. Res. 1999;428:125–130
  31. Yokoi T, Kamataki T. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharm. Res. 1998;15:517–524
  32. Zong YS, Sham JS, Ng MH, Ou XT, Guo YQ, Zheng SA, et al. Immunoglobulin a against viral capsid antigen of epstein-barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 1992;69:3–7
  33. Nam JM, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among US whites. J. Natl Cancer Inst. 1992;84:619–622
  34. Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarungsri V. Environmental risk factors for nasopharyngeal carcinoma: a case-control study in north-eastern Thailand. Cancer Epidemiol. Biomarkers Prev. 1992;1:345–348
  35. IARC, IARC Monographs on the evaluation of carcinogenic risks to humans, Epstein–Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8, vol. 70, Lyon, 1997.
  36. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int. J. Cancer. 1998;77:228–235
  37. Ando M, Hamajima N, Ariyoshi N, Kamataki T, Matsuo K, Ohno Y. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. J. Epidemiol. 2003;13:176–181
  38. Kwon JT, Nakajima M, Chai S, Yom YK, Kim HK, Yamazaki H, et al. Nicotine metabolism and CYP2A6 allele frequencies in Koreans. Pharmacogenetics. 2001;11:317–323
  39. Oscarson M, McLellan RA, Gullsten H, Yue QY, Lang MA, Bernal ML, et al. Characterization and PCR-based detection of a CYP2A6 gene deletion found at high frequency in a Chinese population. Fed. Eur. Biochem. Soc. Lett. 1999;448:105–110
  40. Inoue K, Yamazaki H, Shimada T. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians. Arch. Toxicol. 2000;73:532–539
  41. Loriot MA, Rebuissou S, Oscarson M, Cenee S, Miyamoto M, Ariyoshi N, et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics. 2001;11:39–44
  42. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J. Natl Cancer Inst. 1997;89:1207–1212

PII: S0304-3835(05)00944-4

doi: 10.1016/j.canlet.2005.10.026

Cancer Letters
Volume 241, Issue 1 , Pages 135-141 , 8 September 2006

Article Tools

* Image Usage & Resolution